http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0014198-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84b85f529049ce3987890738559fa556 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
filingDate | 2000-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e35ba24671d8c4af799fb26313e8c72f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee23ff6d4f241cf13decebb6302fecf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f95f59553588b26f07142340b06e884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e3379d07b6be0c8ff0461e150d2738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c98ddb08df0ff5d07d751fe7c7efc54 |
publicationDate | 2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-0014198-A |
titleOfInvention | Process for the therapeutic management of extra-uterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
abstract | Invention Patent: "PROCESS FOR THE THERAPEUTIC MANAGEMENT OF EXTRA-UTERINE PROLIFERATION OF ENDOMETRIAL TISSUE, CHRONIC PELVIC PAIN AND Phallus TUBE OBSTRUCTION". The present invention relates to a process for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction as an LH-RH antagonist by short-term induction treatment for a period of about 4 to 12 weeks. According to another aspect of the present invention, short-term treatment with LH-RH is followed by combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-rheumatic agent steroidal, an analgesic, an androgen other than 17-alpha-substituted testosterone or any combinations thereof. In accordance with a further aspect of the present invention, a pharmaceutical composition is provided comprising an LH-RH antagonist and one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal antirheumatic agent, an analgesic , an androgen other than 17-alpha-substituted testosterone or any combinations thereof. |
priorityDate | 1999-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.